Clinical trial · Interventional
Exercise Intervention in Breast Cancer Patients With Treatment-Induced Arthralgia
NCT01236417CI-TRIAL-00006713completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a pilot study of a specifically designed exercise intervention developed for breast cancer patients with aromatase-inhibitor related joint pain.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Arthralgia | — | UNRESOLVED | — |
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Exercising block | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Exercise
- description
- Subjects will be participating in a home-based flexibility and exercise program
- interventionNames
- Behavioral: Exercising block
Primary outcomes (1)
- measure
- Effects of exercise
- timeFrame
- Length of study
- description
- To assess the effect of an exercise intervention in breast cancer patients with arthralgia secondary to adjuvant treatment with aromatase inhibitors.
Secondary outcomes (1)
- measure
- Feasibility of Multi-institutional study
- timeFrame
- Length of the study
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Post menopausal women with a history of estrogen positive breast cancer who are receiving aromatase inhibitors for at least one month. * Patients must complain of mild to moderate arthralgia. * Ability to understand and sign informed consent. * Patients meet criteria for low to moderate risk for moderate exercise based oon the ACSM guidelines. Exclusion Criteria: * Inability to comply with study requirements. * Metastatic breast cancer. * Patients with orthopedic or neuromuscular disorders that preclude participation in exercise. * Rheumatoid arthritis. * History of MI, angina or congestive heart failure. * Pregnant or lactating females. * Patients that are high risk for moderate exercise based on ACSM risk classification. * Patients who exceed minimal physical activity recommendations from the US Surgeon General's Report: Accumulation of 30 minutes or more of moderate physical activity on most days of the week. * Morbidly obese with BMI ≥ 40
References
Publications (0)
Data not yet available
No reference posted for this study.